Document is current
Any future updates will be listed below
-
Authors
Callis Duffin, Kristina
Bushmakin, Andrew G.
Cappelleri, Joseph C.
Mallbris, Lotus
Mamolo, Carla http://orcid.org/0000-0001-5321-561X
-
Funding
Funding for this research was provided by:
Pfizer Inc
- License Information
-
More Information
Article History
Received: 22 September 2017
Accepted: 17 May 2019
First Online: 7 June 2019
Ethics approval and consent to participate
: All clinical studies were conducted in compliance with the ethical principles originating in, or derived from, the Declaration of Helsinki, and with the International Council for Harmonisation Good Clinical Practice Guidelines. All documentation was reviewed by the institutional review board and/or independent ethics committee at each of the investigational centres (Additional file InternalRef removed). All patients provided written informed consent.
: Not applicable.
: KCD has served as an investigator and/or consultant for Amgen, AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, Stiefel, Novartis and Pfizer Inc.AGB, JCC and CM are employees and stockholders of Pfizer Inc. LM was an employee of Pfizer Inc and held stock/stock options in Pfizer Inc at the time of the analysis.
